• 제목/요약/키워드: Genetic factor

검색결과 1,185건 처리시간 1.823초

Inter-Pillar 진동 모드를 고려한 1-3형 압전복합체의 구조 최적화 (Optimization of 1-3 Type Piezocomposite Structures Considering Inter-Pillar Vibration Modes)

  • 표성훈;김진욱;노용래
    • 한국전기전자재료학회논문지
    • /
    • 제26권6호
    • /
    • pp.434-440
    • /
    • 2013
  • With polymer properties and ceramic volume fraction as design variables, the optimal structure of 1-3 piezocomposites has been determined to maximize the thickness mode electromechanical coupling factor. When the piezocomposite vibrates in a thickness mode, inter-pillar resonant modes are likely to occur between lattice-structured piezoceramic pillars and polymer matrix, which significantly deteriorates the performance of the piezocomposite. In this work, a new method to design the structure of the 1-3 type piezocomposite is proposed to maximize the thickness mode electromechanical coupling factor while preventing the occurrence of the inter-pillar modes. Genetic algorithm was used for the optimal design, and the finite element analysis method was used for the analysis of the inter-pillar mode.

Biological Therapy for Inflammatory Bowel Disease in Children

  • Na, So-Young;Shim, Jung-Ok
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제15권1호
    • /
    • pp.13-18
    • /
    • 2012
  • The pathogenesis of inflammatory bowel diseases is not very well understood; it is currently thought to be caused by the interaction between genetic factors, environmental factors, intestinal microbes, and immune factors. Biological agents such as anti-tumor necrosis factor (anti-TNF) are widely being used as therapeutic agents. Infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, has been demonstrated to have an effect in the induction and maintenance of remission in Crohn's disease in children. The effects of biological agents, typified by anti-TNFs, in inflammatory bowel disease in children; the recent concern on the administration of biological agents in combination with immunomodulators; and 'Top-down' therapy are some of the topics covered in this review.

Discovering cis-regulatory motifs by combining multiple predictors

  • Chang, Hye-Shik;Hwang, Kyu-Woong;Kim, Dong-Sup
    • Bioinformatics and Biosystems
    • /
    • 제2권2호
    • /
    • pp.52-57
    • /
    • 2007
  • The computational discovery of transcription factor binding site is one of the important tools in the genetic and genomic analysis. Rough prediction of gene regulation network and finding possible co-regulated genes are typical applications of the technique. Countless motif-discovery algorithms have been proposed for the past years. However, there is no dominant algorithm yet. Each algorithm does not give enough accuracy without extensive information. In this paper, we explore the possibility of combining multiple algorithms for the one integrated result in order to improve the performance and the convenience of researchers. Moreover, we apply new high order information that is reorganized from the set of basis predictions to the final prediction.

  • PDF

A case of thanatophoric dysplasia type I with an R248C mutation in the $FGFR3$ gene

  • Noe, Eun-Jung;Yoo, Han-Wook;Kim, Kwang-Nam;Lee, So-Yeon
    • Clinical and Experimental Pediatrics
    • /
    • 제53권12호
    • /
    • pp.1022-1025
    • /
    • 2010
  • Thanatophoric dysplasia (TD) is a short-limb neonatal dwarfism syndrome that is usually lethal in the perinatal period. It is characterized by shortening of the limbs, severely small thorax, large head with a prominent forehead, macrocephaly, curved femur, and flattened vertebral bodies. These malformations result from the mutation in fibroblast growth factor receptor 3 (FGFR-3) gene which is located on the short arm of chromosome 4. A definite diagnosis should be established by molecular genetic analysis to find out the abnormal mutations in the $FGFR3$ gene. We confirmed by detection of a R248C mutation in the $FGFR3$ gene in DNA analysis.

지능(知能)에 관(關)한 동서의학적(東西醫學的) 고찰(考察) (Review of Intelligence and Memory)

  • 서영민;김장현
    • 대한한방소아과학회지
    • /
    • 제13권1호
    • /
    • pp.139-166
    • /
    • 1999
  • The purpose of this review is to determine oriental concept of intelligence and memory, and to minimize adverse effect during treatment of brain disease by western medicine. Intelligence is developed by interaction between genetic factor ane environmental factor in Western medicine, Wherease mental function is difined by 'Chilsin' or 'Ohsin', and brain which control intelligence and memory is define by part of heart in oriental medicine The conception that mind and body are sameone may show possibility of intelligence and memory enhancement, and it may be usefule to clinical application.

  • PDF

Linkage Disequilibrium (LD) Mapping and Tagging SNP Selection of C-Fos Induced Growth Factor (Figf) Gene in Korean Population

  • Kim, Sook;Yoo, Yeon-Kyung;Jang, Hye-Yoon;Shin, Eun-Soon;Cho, Eun-Young;Kim, Eu-Gene;NamKung, Jung-Hyun;Yang, Jun-Mo;Lee, Jong-Eun
    • Molecular & Cellular Toxicology
    • /
    • 제2권1호
    • /
    • pp.7-10
    • /
    • 2006
  • We performed comprehensive SNP validation and linkage disequilibrium (LD) analysis of the c-fos induced growth factor (Figf) gene in Korean population. Out of 32 SNPs, only 9 SNPs were polymorphic in Korean population. Validated SNPs formed a single extended haplotype block with strong LD through the entire length of the gene. Tagging SNP analysis picked only 2 SNPs to represent most of the genetic variation information of the Figf gene. Our results demonstrate the utility of LD block and tagging SNP analysis for an efficient way of performing a candidate gene based association study.

Rapid Resolution of Atypical Hemolytic Uremic Syndrome by Eculizumab Treatment

  • Kim, Min Seung;Lim, Seon Hee;Kim, Ji Hyun;Ha, Il-Soo;Cheong, Hae Il;Kang, Hee Gyung
    • Childhood Kidney Diseases
    • /
    • 제24권2호
    • /
    • pp.138-142
    • /
    • 2020
  • Atypical hemolytic uremic syndrome (aHUS) is an extremely rare and life-threatening disorder. Typical HUS is often caused by Shiga toxin-positive Escherichia coli, while aHUS is caused by dysregulation of the alternative pathway of the complement system in association with genetic abnormalities or development of autoantibodies. Eculizumab, a humanized anti-complement 5 monoclonal antibody, is recommended for the treatment of aHUS, but its long-term safety and efficacy in pediatric patients remain under review. In this paper, we report a pediatric case of aHUS with anti-complement factor H autoantibodies, who was treated successfully with eculizumab.

Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases

  • Moon, Jin Soo
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제22권1호
    • /
    • pp.50-56
    • /
    • 2019
  • The incidence of pediatric inflammatory bowel disease (IBD) is increasing worldwide, especially in the developing countries. It differs from adult disease in clinical manifestations, especially with regard to genetic predisposition in monogenic IBD. Pediatric disease also have a tendency to show more aggressive inflammation and greater extent of lesion. Newer drugs such as anti-tumor necrosis factor ${\alpha}$ have been known to make a difference in treating pediatric IBD. Recent studies suggested that the patients with high risk factors might have some benefits from earlier use of biologics. To achieve treatment goals such as relieving symptoms, optimizing growth, and improving quality of life while minimizing drug toxicity, more research is needed to develop tools for risk stratification in the use of biologics for pediatric IBD.

A Korean case of CTCF related neurodevelopmental disorders

  • Seong Ryeong Kang;Soo Hyun Seo;Kyunghoon Kim;Hee Bum Yang;Hye Ran Yang;Anna Cho
    • Journal of Genetic Medicine
    • /
    • 제20권2호
    • /
    • pp.70-74
    • /
    • 2023
  • CCCTC-binding factor (CTCF) is a transcriptional regulator that binds to a complex DNA motif in various orientations and plays a crucial role in regulating gene expression, chromatin restructuring, and developmental processes. Mutations in the CTCF are associated with neurodevelopmental disorders. Here we report the first Korean case with a de novo heterozygous variant in the CTCF (c.1025G>A; p.Arg342His). She showed global developmental delay, failure to thrive, and dysmorphic face, which are phenotypes consistent with previous reports in the autosomal dominant intellectual developmental disorder 21 (MIM 615502). She also showed clinical features not previously reported, such as antral web and tracheobronchomalacia. Our case follows suit and expands understanding of this rare disorder by reporting common features and, on the other hand, unreported concomitant congenital anomalies.

Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes

  • Lee, Jin Sol;Cheong, Hyun Sub;Kim, Lyoung Hyo;Kim, Ji On;Seo, Doo Won;Kim, Young Hoon;Chung, Myeon Woo;Han, Soon Young;Shin, Hyoung Doo
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제17권6호
    • /
    • pp.479-484
    • /
    • 2013
  • Given the CYP3A4 and CYP3A5's impact on the efficacy of drugs, the genetic backgrounds of individuals and populations are regarded as an important factor to be considered in the prescription of personalized medicine. However, genetic studies with Korean population are relatively scarce compared to those with other populations. In this study, we aimed to identify CYP3A4/5 polymorphisms and compare the genotype distributions among five ethnicities. To identify CYP3A4/5 SNPs, we first performed direct sequencing with 288 DNA samples which consisted of 96 Koreans, 48 European-Americans, 48 African-Americans, 48 Han Chinese, and 48 Japanese. The direct sequencing identified 15 novel SNPs, as well as 42 known polymorphisms. We defined the genotype distributions, and compared the allele frequencies among five ethnicities. The results showed that minor allele frequencies of Korean population were similar with those of the Japanese and Han Chinese populations, whereas there were distinct differences from European-Americans or African-Americans. Among the pharmacogenetic markers, frequencies of $CYP3A4^*1B$ (rs2740574) and $CYP3A5^*3C$ (rs776742) in Asian groups were different from those in other populations. In addition, minor allele frequency of $CYP3A4^*18$ (rs28371759) was the highest in Korean population. Additional in silico analysis predicted that two novel non-synonymous SNPs in CYP3A5 (+27256C>T, P389S and +31546T>G, I488S) could alter protein structure. The frequency distributions of the identified polymorphisms in the present study may contribute to the expansion of pharmacogenetic knowledge.